Ultragenyx Pharmaceutical Inc header image

Ultragenyx Pharmaceutical Inc

RARE

Equity

ISIN null / Valor 22860122

NASDAQ (2026-10-23)
USD 15.65-1.88%

Ultragenyx Pharmaceutical Inc
UMushroom community rating:

star star star star star
3.17 12 votes No rating yet
NegativeNeutralPositive

About company

Ultragenyx Pharmaceutical Inc is a biopharmaceutical company that focuses on developing and commercializing innovative treatments for rare and ultra-rare genetic diseases. The company's portfolio includes products such as DOJOLVI® for long-chain fatty acid oxidation disorders and CRYSVITA® for X-linked hypophosphatemia and tumor-induced osteomalacia. Ultragenyx is dedicated to providing patients with life-changing therapies that address unmet medical needs in the rare disease community.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-53.5%1Y
-51.1%3Y
-80.0%5Y

Performance

96.6%1Y
69.0%3Y
63.1%5Y

Volatility

Market cap

1543 M

Market cap (USD)

Daily traded volume (Shares)

1,789,662

Daily traded volume (Shares)

1 day high/low

43.045 / 41.53

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.17

12 votes
Performance:
starstarstarstarstar
3.50
Innovation:
starstarstarstarstar
3.50
Society:
starstarstarstarstar
3.42
Nature:
starstarstarstarstar
3.17
Hazem Baderon
Malaysia, 20 May 2026
star star star star star
Still consolidating, might be ok for long term
Han Yee Kong
Malaysia, 29 Apr 2026
star star star star star
.
oliver baigel
UK, 09 Nov 2025
star star star star star
a very low performing stock with a high level of risk

EQUITIES OF THE SAME SECTOR

Biocon Limited
Biocon Limited Biocon Limited Valor: 1806852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%INR 326.60
Max Healthcare Institute Ltd
Max Healthcare Institute Ltd Max Healthcare Institute Ltd Valor: 45624817
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.44%INR 817.00
Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc Madrigal Pharmaceuticals Inc Valor: 33395434
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.21%USD 434.24
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.85%USD 13.73
National Vision Holdings Inc
National Vision Holdings Inc National Vision Holdings Inc Valor: 38523646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.06%USD 18.67
Eris Lifesciences Ltd
Eris Lifesciences Ltd Eris Lifesciences Ltd Valor: 37115190
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.14%INR 1,097.65
Cohance Lifesciences Ltd
Cohance Lifesciences Ltd Cohance Lifesciences Ltd Valor: 46346459
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.59%INR 448.65
IPCA Laboratories Limited
IPCA Laboratories Limited IPCA Laboratories Limited Valor: 115718957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.55%INR 1,951.25
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.56%EUR 17.90
Viyash Scientific Limited
Viyash Scientific Limited Viyash Scientific Limited Valor: 31559309
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.07%INR 203.45